U.S. Could Have Had Many More Doses of Monkeypox Vaccine This Year - The New York Times

The Department of Health and Human Services delayed asking the manufacturer to process the bulk vaccine the government already owned into vials.

Bavarian Nordic was able to develop the vaccine, which also works against smallpox, largely thanks to the federal governments backing, which surpassed $1 billion in 2014 and is now edging toward $2 b… [+1701 chars]

full article...